FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048591097> ?p ?o ?g. }

• W3048591097 endingPage "5" @default.
• W3048591097 startingPage "1" @default.
• W3048591097 abstract "The aim of this study was to assess the effect of intravitreal injections (IVI) of ranibizumab and aflibercept on the choroidal thickness (CT) in patients with treatment-naive diabetic macular edema (DME) before and after monthly IVI. Patients and Methods. Prospective monocenter study. Inclusion criteria were treatment-naive DME eyes without concomitant panretinal photocoagulation, associated with a decrease in best-corrected visual acuity ≤75 letters on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. DME was defined by a central retinal thickness ≥300 μm on swept-source OCT (Triton DRI OCT, Topcon Corporation, Itabashi, Japan). Patients received 5 IVI of ranibizumab or aflibercept. The primary endpoint was the change in the central subfield CT (CSCT) between inclusion (M0) and 1 month after the fifth IVI (M5). The secondary endpoint was the CT changes between M0 and M5 in other locations of the macular ETDRS grid.Twenty-four eyes of 24 patients with a mean age of 61.1 years were included. Eleven and 13 patients were, respectively, treated with ranibizumab and aflibercept, and 86.4% had type 2 diabetes. The overall CSCT decreased significantly by -12 μm between M0 and M5 (231.7 μm at M0 and 219.7 μm at M5) (p=0.03). It decreased by -15.2 μm (p=0.02) in the aflibercept group (206.9 μm at M0 and 191.7 μm at M5) and by -7.3 μm (p=0.4) in the ranibizumab group (267.5 μm at M0 and 260.2 μm at M5). The CSCT decreased by -4.9 μm in noninjected contralateral eyes (242.3 μm at M0 and 237.4 μm at M5). CT changes between M0 and M5 in the superior, temporal, inferior, and nasal macular inner ring were significant in the aflibercept group but not in the ranibizumab and control groups.In DME patients, the CSCT decreases after 5 IVI of anti-VEGF, especially after aflibercept treatment." @default.
• W3048591097 created "2020-08-18" @default.
• W3048591097 creator A5011449827 @default.
• W3048591097 creator A5045288418 @default.
• W3048591097 creator A5057357453 @default.
• W3048591097 creator A5059186884 @default.
• W3048591097 creator A5073889285 @default.
• W3048591097 date "2020-08-12" @default.
• W3048591097 modified "2023-10-12" @default.
• W3048591097 title "Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema" @default.
• W3048591097 cites W1851779742 @default.
• W3048591097 cites W1968719918 @default.
• W3048591097 cites W2012407775 @default.
• W3048591097 cites W2019378912 @default.
• W3048591097 cites W2088255003 @default.
• W3048591097 cites W2106466837 @default.
• W3048591097 cites W2170632654 @default.
• W3048591097 cites W2177844192 @default.
• W3048591097 cites W2293726653 @default.
• W3048591097 cites W2295225445 @default.
• W3048591097 cites W2509203504 @default.
• W3048591097 cites W2574389247 @default.
• W3048591097 cites W2605915718 @default.
• W3048591097 cites W2606014350 @default.
• W3048591097 cites W2766371567 @default.
• W3048591097 cites W2768117688 @default.
• W3048591097 cites W2791823227 @default.
• W3048591097 cites W2884425125 @default.
• W3048591097 cites W922383587 @default.
• W3048591097 doi "https://doi.org/10.1155/2020/5708354" @default.
• W3048591097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7441456" @default.
• W3048591097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32850142" @default.
• W3048591097 hasPublicationYear "2020" @default.
• W3048591097 type Work @default.
• W3048591097 sameAs 3048591097 @default.
• W3048591097 citedByCount "4" @default.
• W3048591097 countsByYear W30485910972021 @default.
• W3048591097 countsByYear W30485910972022 @default.
• W3048591097 countsByYear W30485910972023 @default.
• W3048591097 crossrefType "journal-article" @default.
• W3048591097 hasAuthorship W3048591097A5011449827 @default.
• W3048591097 hasAuthorship W3048591097A5045288418 @default.
• W3048591097 hasAuthorship W3048591097A5057357453 @default.
• W3048591097 hasAuthorship W3048591097A5059186884 @default.
• W3048591097 hasAuthorship W3048591097A5073889285 @default.
• W3048591097 hasBestOaLocation W30485910971 @default.
• W3048591097 hasConcept C118487528 @default.
• W3048591097 hasConcept C134018914 @default.
• W3048591097 hasConcept C141071460 @default.
• W3048591097 hasConcept C168563851 @default.
• W3048591097 hasConcept C188816634 @default.
• W3048591097 hasConcept C203092338 @default.
• W3048591097 hasConcept C2776694085 @default.
• W3048591097 hasConcept C2777802072 @default.
• W3048591097 hasConcept C2778257484 @default.
• W3048591097 hasConcept C2778749236 @default.
• W3048591097 hasConcept C2779384505 @default.
• W3048591097 hasConcept C2779829184 @default.
• W3048591097 hasConcept C2780347916 @default.
• W3048591097 hasConcept C2781100027 @default.
• W3048591097 hasConcept C2985127711 @default.
• W3048591097 hasConcept C555293320 @default.
• W3048591097 hasConcept C71924100 @default.
• W3048591097 hasConceptScore W3048591097C118487528 @default.
• W3048591097 hasConceptScore W3048591097C134018914 @default.
• W3048591097 hasConceptScore W3048591097C141071460 @default.
• W3048591097 hasConceptScore W3048591097C168563851 @default.
• W3048591097 hasConceptScore W3048591097C188816634 @default.
• W3048591097 hasConceptScore W3048591097C203092338 @default.
• W3048591097 hasConceptScore W3048591097C2776694085 @default.
• W3048591097 hasConceptScore W3048591097C2777802072 @default.
• W3048591097 hasConceptScore W3048591097C2778257484 @default.
• W3048591097 hasConceptScore W3048591097C2778749236 @default.
• W3048591097 hasConceptScore W3048591097C2779384505 @default.
• W3048591097 hasConceptScore W3048591097C2779829184 @default.
• W3048591097 hasConceptScore W3048591097C2780347916 @default.
• W3048591097 hasConceptScore W3048591097C2781100027 @default.
• W3048591097 hasConceptScore W3048591097C2985127711 @default.
• W3048591097 hasConceptScore W3048591097C555293320 @default.
• W3048591097 hasConceptScore W3048591097C71924100 @default.
• W3048591097 hasLocation W30485910971 @default.
• W3048591097 hasLocation W30485910972 @default.
• W3048591097 hasLocation W30485910973 @default.
• W3048591097 hasLocation W30485910974 @default.
• W3048591097 hasOpenAccess W3048591097 @default.
• W3048591097 hasPrimaryLocation W30485910971 @default.
• W3048591097 hasRelatedWork W2036661104 @default.
• W3048591097 hasRelatedWork W2600874963 @default.
• W3048591097 hasRelatedWork W2790038519 @default.
• W3048591097 hasRelatedWork W2981977889 @default.
• W3048591097 hasRelatedWork W2982026403 @default.
• W3048591097 hasRelatedWork W2990901999 @default.
• W3048591097 hasRelatedWork W3136558146 @default.
• W3048591097 hasRelatedWork W3166614601 @default.
• W3048591097 hasRelatedWork W3172842607 @default.
• W3048591097 hasRelatedWork W4226452359 @default.
• W3048591097 hasVolume "2020" @default.
• W3048591097 isParatext "false" @default.

• next